CXCR2 and pulmonary fibrosis: For example, the antagonism of the chemokine receptor CXCR2 was able to reduce neutrophil recruitment and improved tissue damage in asthma [37], in LPS-induced acute inflammation [38], and in bleomycin-induced lung fibrosis [39].